Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease.

de Jong MH, Zemel D, Van Gool AR.

Clin Schizophr Relat Psychoses. 2014 Apr;8(1):36-40. doi: 10.3371/CSRP.DEZE.012513.

PMID:
23428786
[PubMed - in process]
2.

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.

Friedman JH, Factor SA.

Mov Disord. 2000 Mar;15(2):201-11. Review.

PMID:
10752567
[PubMed - indexed for MEDLINE]
3.

Management of psychotic aspects of Parkinson's disease.

Juncos JL.

J Clin Psychiatry. 1999;60 Suppl 8:42-53. Review.

PMID:
10335670
[PubMed - indexed for MEDLINE]
4.

Treatment of psychosis in Parkinson's disease: safety considerations.

Fernandez HH, Trieschmann ME, Friedman JH.

Drug Saf. 2003;26(9):643-59. Review.

PMID:
12814332
[PubMed - indexed for MEDLINE]
5.

[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].

Drach LM.

Med Monatsschr Pharm. 2011 Feb;34(2):47-52; quiz 53-4. Review. German.

PMID:
21428015
[PubMed - indexed for MEDLINE]
6.

Management of psychosis in Parkinson's disease.

Wolters EC, Berendse HW.

Curr Opin Neurol. 2001 Aug;14(4):499-504. Review.

PMID:
11470967
[PubMed - indexed for MEDLINE]
7.

The diagnosis of manganese-induced parkinsonism.

Cersosimo MG, Koller WC.

Neurotoxicology. 2006 May;27(3):340-6. Epub 2005 Dec 1. Review.

PMID:
16325915
[PubMed - indexed for MEDLINE]
8.

[Psychic disorders].

Pollak P.

Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S125-31. Review. French.

PMID:
12690672
[PubMed - indexed for MEDLINE]
9.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
10.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
11.

Helicobacter pylori eradication for Parkinson's disease.

Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008453. doi: 10.1002/14651858.CD008453.pub2. Review.

PMID:
22071847
[PubMed - indexed for MEDLINE]
12.

EPS profiles: the atypical antipsychotics are not all the same.

Weiden PJ.

J Psychiatr Pract. 2007 Jan;13(1):13-24. Review.

PMID:
17242588
[PubMed - indexed for MEDLINE]
13.

Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.

Hoy SM, Keating GM.

Drugs. 2012 Mar 26;72(5):643-69. doi: 10.2165/11207560-000000000-00000. Review. Erratum in: Drugs. 2012 Apr 16;72(6):870-1.

PMID:
22439669
[PubMed - indexed for MEDLINE]
14.

Amantadine in Parkinson's disease.

Crosby N, Deane KH, Clarke CE.

Cochrane Database Syst Rev. 2003;(1):CD003468. Review.

PMID:
12535476
[PubMed - indexed for MEDLINE]
15.

Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics.

Ferentinos P, Dikeos D.

Curr Opin Psychiatry. 2012 Sep;25(5):381-90. doi: 10.1097/YCO.0b013e3283568537. Review.

PMID:
22842659
[PubMed - indexed for MEDLINE]
16.

[Clozapine in the treatment of mental manifestations of Parkinson disease].

Diederich N, Keipes M, Graas M, Metz H.

Rev Neurol (Paris). 1995 Apr;151(4):251-7. Review. French.

PMID:
7481376
[PubMed - indexed for MEDLINE]
17.

Treatment options for depression and psychosis in Parkinson's disease.

Poewe W, Seppi K.

J Neurol. 2001 Sep;248 Suppl 3:III12-21. Review.

PMID:
11697683
[PubMed - indexed for MEDLINE]
18.

Psychosis in Parkinson's disease: therapeutic options.

Hasnain M.

Drugs Today (Barc). 2011 May;47(5):353-67. doi: 10.1358/dot.2011.47.5.1584113. Review.

PMID:
22013566
[PubMed - indexed for MEDLINE]
19.

Drug-induced parkinsonism in the elderly: incidence, management and prevention.

López-Sendón JL, Mena MA, de Yébenes JG.

Drugs Aging. 2012 Feb 1;29(2):105-18. doi: 10.2165/11598540-000000000-00000. Review.

PMID:
22250585
[PubMed - indexed for MEDLINE]
20.

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004554. Review.

PMID:
15495119
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk